文献速递多重用药衰弱、肌少症与跌倒老年综合评估

老年住院患者院内用药调整与出院后28天临床结局的关联

Impact of in-hospital medication changes on clinical outcomes in older inpatients: the journey and destination.
PubMed 文献 · Age Ageing · 2025-01-01

回顾性队列纳入2000例≥75岁住院患者,评估院内用药调整与出院后28天急诊就诊、再入院和死亡的关系。在出院带药5-9种的患者中,减少潜在不适当用药(PIM)和减少Drug Burden Index(DBI)贡献药物与急诊就诊及再入院风险降低相关,而≤4种和≥10种组未见关联。

要点

  • 出院带药5-9种的老年患者中,减少PIM与急诊就诊和再入院风险降低相关。
  • 减少DBI贡献药物与再入院风险降低相关,减少PIM差值亦与急诊风险降低相关。
  • 出院带药≤4种或≥10种的患者中,用药调整与结局无显著关联。

核心结论

  • 院内用药调整与出院带药5-9种的老年患者28天急诊就诊和再入院风险降低相关。
  • 在出院带药≤4种和≥10种的患者中,未观察到用药调整与临床结局的关联。
  • 敏感性分析中,所有组别用药调整与死亡率均无关联。

研究设计与样本

  • 回顾性队列研究,纳入2000例年龄≥75岁的住院患者。
  • 用药调整包括所有药物、DBI贡献药物和Beers Criteria 2015 PIM的增加与减少数量,以及出院与入院时药物数、PIM数和DBI评分的差值。
  • 采用logistic回归分析28天急诊就诊、再入院和死亡结局,调整年龄、性别和主要诊断。
  • 死亡率敏感性分析排除了临终患者。
  • 患者按出院带药数量分为≤4种、5-9种和≥10种三组。

主要发现

  • 平均年龄86岁(SD=5.8),女性占59.1%。

关键数值与推荐

  • 出院带药≤4种和≥10种组:用药调整与急诊、再入院和死亡均无显著关联。

临床怎么用

  • 对出院带药5-9种的≥75岁住院患者,可考虑通过减少PIM和DBI贡献药物来降低28天急诊和再入院风险。
  • 用药调整的获益可能因出院带药总数而异,需结合患者个体情况评估。

局限性

  • 本研究为回顾性队列,无法确定因果关系。
  • 仅纳入≥75岁住院患者,结论外推需谨慎。
  • 原文未报告其他潜在混杂因素的调整情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medication review is integral in the pharmacological management of older inpatients. OBJECTIVE: To assess the association of in-hospital medication changes with 28-day postdischarge clinical outcomes. METHODS: Retrospective cohort of 2000 inpatients aged ≥75 years. Medication changes included the number of increases (medications started or dose-increased) and decreases (medications stopped or dose-decreased) for (i) all medications, (ii) Drug Burden Index (DBI)-contributing medications and (iii) Beers Criteria 2015 medications (potentially inappropriate medications, PIMs). Changes also included differences in (i) the number of medications, (ii) the number of PIMs and (iii) DBI score, at discharge versus admission. Associations with clinical outcomes (28-day ED visit, readmission and mortality) were ascertained using logistic regression, adjusted for age, gender and principal diagnosis. For mortality, sensitivity analysis excluded end-of-life patients due to higher death risk. Patients were stratified into : (i) ≤4, (ii) 5-9 and (iii) ≥10 discharge medications. RESULTS: The mean age was 86 years (SD = 5.8), with 59.1% female. Medication changes reduced ED visits and readmission risk for patients prescribed five to nine discharge medications, with no associations in patients prescribed ≤4 and ≥ 10 medications. In the five to nine medications group, decreasing PIMs reduced risks of ED visit (adjusted odds ratio, aOR 0.55, 95% CI 0.34-0.91, P = .02) and readmission (aOR 0.62, 95% CI 0.38-0.99, P = .04). Decreasing DBI-contributing medications reduced readmission risk (aOR 0.71, 95% CI 0.51-0.99, P = .04). Differences in PIMs reduced ED visit risk (aOR 0.65, 95% CI 0.43-0.99, P = .04). There were no associations with mortality in sensitivity analyses in all groups. DISCUSSION: Medication changes were associated with reduced ED visits and readmission for patients prescribed five to nine discharge medications.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Masnoon N, Lo S, Gnjidic D, et al. Impact of in-hospital medication changes on clinical outcomes in older inpatients: the journey and destination. Age Ageing. 2025. PMID: 39895509. doi:10.1093/ageing/afae282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。